42 results
424B5
ICON Operational Financing Unlimited Co
26 Apr 24
Prospectus supplement for primary offering
9:41am
in their development processes, convert previously fixed costs to variable, and accelerate time to market for new treatments.
We believe regulatory and reimbursement … reimbursement. Furthermore, we believe advances in molecular biology and genetics will drive further growth in innovation in the long term which in turn
6-K
EX-99.1
ICLR
Icon Plc
25 Apr 24
Third Amendment to Credit Agreement
4:32pm
Disbursements which are the subject of a borrowing, drawing, payment, reimbursement or rate selection are denominated in euros, the term “Business Day” shall also … or in respect of any of the Loans made or reimbursement or other obligations incurred or any of the Letters of Credit or other instruments at any time
6-K
EX-99.3
ICLR
Icon Plc
12 Jun 23
Notice of Annual General Meeting
8:07am
in their development processes, convert previously fixed costs to variable, and accelerate time to market for new treatments.
Regulatory and reimbursement … reimbursement. Furthermore, we believe advances in molecular biology and genetics will drive further growth in innovation in the long term which in turn should
6-K
EX-99.3
ICLR
Icon Plc
17 Jun 22
Notice of Annual General Meeting
9:12am
and test these in parallel in several therapeutic indications or with other drug combinations.
Regulatory and reimbursement pressures will increase … , outcomes and comparative effectiveness research will most likely be required in order to secure on-going product reimbursement. Furthermore, we believe
6-K
8vpaq09fh1phvht go9
9 Nov 21
Current report (foreign)
4:23pm
6-K
vwr7u1i4k2mzqfav d4
23 Jul 21
Current report (foreign)
8:21am
6-K
EX-99.1
74ylde ecf7k6tq
21 Jul 21
Icon PLC 6-K
4:20pm
6-K
EX-99.2
amjt593k
1 Jul 21
Current report (foreign)
8:54am
6-K
EX-99.1
9dou actllu
1 Jul 21
Current report (foreign)
8:54am
6-K
EX-99.3
i52tuey7e5cw
16 Jun 21
Notice of Annual General Meeting
4:16pm
6-K
zvox29a
30 Apr 21
Current report (foreign)
6:18am
424B3
mrixkw 9wxiq
28 Apr 21
Prospectus supplement
12:00am
F-4/A
o6ptxwbjs2ijky
26 Apr 21
Registration of securities (foreign) (amended)
9:11pm
F-4
d9pe8tt otrh
31 Mar 21
Registration of securities (foreign)
9:09am
425
EX-2.1
7k9h ot3b
24 Feb 21
Business combination disclosure
5:23pm
425
bbiycgchzconyfu8u
24 Feb 21
Business combination disclosure
5:23pm
6-K
cc1dl
24 Feb 21
ICON to acquire PRA Health Sciences, creating a world leader in Healthcare Intelligence and Clinical Research
4:21pm
6-K
EX-2.1
s1o0t2ju 9pdw
24 Feb 21
ICON to acquire PRA Health Sciences, creating a world leader in Healthcare Intelligence and Clinical Research
4:21pm